Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd.
PP-UNP-GBR-10742 / November 2024
All content for Breakthroughs is the property of Pfizer and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd.
PP-UNP-GBR-10742 / November 2024
Meeting the challenge of Antimicrobial Resistance (AMR)
Breakthroughs
36 minutes 13 seconds
2 years ago
Meeting the challenge of Antimicrobial Resistance (AMR)
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-11741 / March 2025
Breakthroughs
Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd.
PP-UNP-GBR-10742 / November 2024
